Health Care/Hospital

Innovent Dosed First Participant in Phase 3 Clinical Study (Neoshot) of IBI310 (Anti-CTLA-4 Monoclonal Antibody) in Combination with Sintilimab for MSI-H/dMMR Colon Cancer Neoadjuvant Therapy

ROCKVILLE, Md. and SUZHOU, China, March 27, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology a...

2024-03-27 08:00 468

Beauty Industry's Largest Acquisition to Date in 2024, Beauty Farm Acquires 70% of Naturade, China's Second-Largest Industry Player

HONG KONG, March 27, 2024 /PRNewswire/ -- Beauty Farm Medical and Health Industry Inc. ("Beauty Farm" or the "Company")(02373.HK), one of China's largest beauty and wellness service providers and aesthetics medical brands, is pleased to announce its acquisition of a 70% equity interest in the cor...

2024-03-27 07:30 1046

World First Use of Lightpoint's SENSEI® Drop-In Gamma Probe in Bladder Cancer Surgery Performed in Spain

LONDON, March 27, 2024 /PRNewswire/ -- Lightpoint Surgical Limited (Lightpoint), an affiliate of Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces a world-first bladder cancer sentinel lymph node (SLN) procedure with SENSEI®, Telix's miniature robotic-assisted gamma pro...

2024-03-27 05:59 349

Texas Cardiac Arrhythmia Institute at St. David's Medical Center to host international conference on complex cardiac arrhythmias

EPLive 2024 is a two-day conference that draws the world's top cardiac electrophysiology experts AUSTIN, Texas, March 26, 2024 /PRNewswire/ -- On April 18 and 19, 2024, the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center will host its seventh international symposium on co...

2024-03-26 23:58 304

ReportLinker Reveals Key Insights About Players and Coverage in Latest Combination Vaccine Market Analysis

LYON, France, March 26, 2024 /PRNewswire/ -- Reportlinker announces the release of the report "A White Paper To Understand The Market Structure Of Pediatric Pertussis Hexavalent and Combination Vaccines

2024-03-26 21:00 661

Nanoscope Therapeutics Announces Positive Top-line Results from Randomized Controlled Trial of MCO-010 for Retinitis Pigmentosa

* MCO-010 achieved its primary and key secondary endpoints with statistical significance and no serious adverse events * Data from the Phase 2b RESTORE trial demonstrate clinically meaningful vision improvement in legally blind individuals with progressive and permanent neurodegeneration of t...

2024-03-26 19:00 717

Beauty Farm Announces 2023 Annual Results

Revenue and Net Profit Reached Record High Acquisition of Naturade, China's Second-Largest Market Share Brand HONG KONG, March 26, 2024 /PRNewswire/ -- Beauty Farm Medical and Health Industry Inc. ("Beauty Farm" or the "Company") (02373.HK), one of the largest beauty and wellness services provide...

2024-03-26 18:25 1373

ANICAV Promotes Sustainability and Wellbeing with Veganism with Legumes from Europe project

SYDNEY, March 26, 2024 /PRNewswire/ -- The Legumes from Europe project, promoted by ANICAV, aims to boost consumption inAustralia of high-quality canned legumes from the "Old Continent". Among the many objectives, improving environmental sustainability and personal well-being and protecting the p...

2024-03-26 18:19 892

Minesto presents today at Naventus Renewables Summit, Stockholm

GOTHENBURG, Sweden, March 26, 2024 /PRNewswire/ -- Minesto's CEO Dr Martin Edlund presents today at Naventus Renewables Summit held in Stockholm, 26 March 2024.   The event is livestreamed, and Minesto will be presenting at 14.40 CET:   Naventus & Partners Renewables Summit 2024 For additional ...

2024-03-26 17:56 702

Cicada Innovations launches HealthTech Hub in Western Sydney's "hidden innovation ecosystem"

SYDNEY, March 26, 2024 /PRNewswire/ -- Australia's flagship deep tech incubator  Cicada Innovations is officially opening the doors to the "Cicada HealthTech Hub " on 25 March 2024, officiated...

2024-03-26 10:00 873

Alphamab Oncology Announces the First Patient Dosed in Australia in the Clinical Study of Subcutaneous Formulation JSKN033

SUZHOU, China, March 26, 2024 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been dosed inAustralia in the clinical study (JSKN033-101) of JSKN033, a subcutaneous formulation with HER2 bispecific antibody-conjugated drug and PD-L1 monoclonal antibody,...

2024-03-26 09:57 912

Scivita Medical Expands Collaboration with Boston Scientific

SUZHOU, China, March 26, 2024 /PRNewswire/ -- Recently, Scivita Medical Technology Co., Ltd. ("Scivita Medical") and Boston Scientific Corporation (NYSE: BSX), a leading global medical technology company, joined hands again to sign an expanded strategic cooperation arrangement.

2024-03-26 09:30 1008

BioDuro-Sundia's Partner, DigmBio Announced IND Clearance from Korea MFDS for its Selective PARP1 Inhibitor DM5167

SHANGHAI, March 26, 2024 /PRNewswire/ -- BioDuro-Sundia's partner, DigmBio, a South Korean biotechnology company, announced its selective PARP1 inhibitor for the treatment of triple-negative breast cancer has been approved by Korea Food and Drug Administration (MFDS) for Investigational New Drug ...

2024-03-26 08:30 906

GenieMD Awarded Frost & Sullivan's 2024 Company of the Year Award for Pioneering Virtual Chronic Disease Management Solutions Through Its Unified Virtual Care Platform

GenieMD offers a comprehensive virtual care platform, integrating telehealth, remote patient monitoring, chronic care management, and AI-driven insights to impact the treatment and management of chronic diseases. SAN ANTONIO, March 25, 2024 /PRNewswire/ -- Frost & Sullivan recently researched th...

2024-03-25 22:31 1153

Sirtex Medical Appoints Matt Schmidt as New Chief Executive Officer and Board of Directors Member

WOBURN, Mass., March 25, 2024 /PRNewswire/ -- Sirtex Medical ("Sirtex"), a leading manufacturer of interventional treatment solutions, announced today the appointment ofMatt Schmidt as chief executive officer and board of directors member, effectiveMarch 25. Since joining Sirtex in 2023, Schmidt...

2024-03-25 20:00 1113

CGTN: China advances battle against tuberculosis

BEIJING, March 25, 2024 /PRNewswire/ -- World Tuberculosis (TB) Day, which falls onMarch 24 every year, is designed to build public awareness that TB today remains a global public health problem that seriously endangers people's health. According to the World Health Organization's (WHO) Global T...

2024-03-25 15:12 1246

ANNOUNCEMENT OF 2023 ANNUAL RESULTS OF TONG REN TANG TECHNOLOGIES

BEIJING, March 25, 2024 /PRNewswire/ -- Tong Ren Tang Technologies Co. Ltd. (" Tong Ren Tang Technologies" or the "Group", 1666.HK) is pleased to announce the audited consolidated results of the Group for the year ended31 December 2023. In 2023, the Group's revenue amounted to RMB6.77 billion, rep...

2024-03-25 12:47 1700

Medipledge, a premium post-laser skincare brand, just launched in Australia

SYDNEY, March 25, 2024 /PRNewswire/ -- On March 24th, 2024, Medipledge, a premium skincare brand developed by experts in beauty and dermatology, successfully launched inAustralia.   The launch event, held in Australia, featured high-tech elements and included high-end aesthetic therapists, lead...

2024-03-25 10:09 779

New PeerLINC Knowledge Hub will Leverage Local Expertise and Experience to Accelerate New, More Effective TB Cures Around the World

Hub will focus on supporting global use of new treatments that effectively treated drug-resistant TB in 98% of Filipino participants MANILA, Australia, March 25, 2024 /PRNewswire/ -- TB Alliance's new Peer-to-Peer Learning for Innovative Cures (PeerLINC) Knowledge Hub launched today inManila, wi...

2024-03-25 10:00 634
12345 ... 551

Week's Top Stories